IRUBIS GmbH
IRUBIS GmbH, founded in 2017, developed Monipa to speed up biological drug market entry using process analytical technology.
Introduction
IRUBIS GmbH, a Munich-based startup co-founded by Anja Müller, Alexander Geißler, and Lorenz Sykora-Mirle in 2017, has innovated with Monipa to expedite the development and market introduction of biological drugs. Monipa represents a transformative process analytical technology that enhances the efficiency and effectiveness of this critical pharmaceutical area.
Information
Categories
More Websites
Shanghai Famo Biotechnology specializes in biomedicine ingredients, production, and technology services.
Beijing Zhejiang Long-Term Biotech produces herbicides, fertilizers, animal feeds, and pre-mixing materials.
Since 1985, process informatik develops future-oriented tech solutions for diverse clients.